Sign in

CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464097528
Phone
617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
  1. SC 13G/A Stake Amended Statement of Ownership
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 1,752 shares at $8.16 ($14,296)
  5. 8-K Event Executive or director change
  6. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 193 shares at $10.23 ($1,974)
  7. 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 102 shares at $10.23 ($1,043)
  8. 8-K Event Other events
  9. 8-K Event Other events
  10. 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 289 shares at $11.02 ($3,185)
  11. 10-Q Report Quarterly Report
  12. 8-K Event Results of operations
  13. SC 13G/A Stake Amended Statement of Ownership
  14. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 192 shares at $15.01 ($2,882)
  15. 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 101 shares at $15.01 ($1,516)
  16. 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 293 shares at $18.60 ($5,449)
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations
  19. 4 Grant or award SVP, CHIEF MEDICAL OFFICER acquired 58,372 shares (grant or award)
  20. 3 Insider Initial Statement of Ownership

Page 13 of 37 · 731 filings